Table of Content

1. PREFACE
1.1. Scope of the Report
1.2. Market Segmentation
1.3. Research Methodology
1.4. Key Questions Answered
1.5. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of 4D Bioprinting
3.3. Working Principle of 4D Bioprinting
3.3.1. Stimuli Responsive Materials in 4D Bioprinting
3.3.1.1. Physical Factors
3.3.1.2. Chemical Factors
3.3.2. Technologies Used in 4D Bioprinting
3.4. Applications of 4D Bioprinting
3.5. Limitations Associated with 4D Bioprinting
3.6. Future Perspectives

4. 4D BIOPRINTERS: MARKET LANDSCAPE
4.1. Chapter Overview
4.2. 4D Bioprinters: Overall Market Landscape
4.2.1. Analysis by Status of Development
4.2.2. Analysis by Type of Biomaterial
4.2.3. Analysis by Status of Development and Type of Biomaterial
4.2.4. Analysis by Type of Technology
4.2.5. Analysis by Status of Development and Type of Technology
4.2.6. Analysis by Type of Stimulus Used
4.2.7. Analysis by Status of Development and Type of Stimulus Used
4.2.8. Analysis by Product Specifications
4.2.9. Analysis by Application Area(s)
4.2.10. Analysis by End-User(s)
4.3. 4D Bioprinter Developers
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Organization Size
4.3.3. Analysis by Location of Headquarters (Region-wise)
4.3.4. Analysis by Organization Size and Location of Headquarters (Region-wise)
4.3.5. Analysis by Location of Headquarters (Country-wise)

5. SMART BIOMATERIALS: MARKET LANDSCAPE
5.1. Chapter Overview
5.2. Smart Biomaterials: Overall Market Landscape
5.2.1. Analysis by Status of Development
5.2.2. Analysis by Type of Biomaterial
5.2.3. Analysis by Status of Development and Type of Biomaterial
5.2.4. Analysis by Form of Biomaterial
5.2.5. Analysis by Type of Stimulus Used
5.2.6. Analysis by Status of Development and Type of Stimulus Used
5.2.7. Analysis by Application Area(s)
5.3. Smart Biomaterials Developers
5.3.1. Analysis by Year of Establishment
5.3.2. Analysis by Organization Size
5.3.3. Analysis by Location of Headquarters (Region-wise)
5.3.4. Analysis by Organization Size and Location of Headquarters (Region-wise)
5.3.5. Analysis by Location of Headquarters (Country-wise)

6. BENCHMARKING ANALYSIS
6.1. Chapter Overview
6.2. Benchmarking Analysis: 4D Bioprinter Developers
6.2.1. Assumptions and Key Parameters
6.2.2. Methodology
6.2.3. Benchmarking Analysis: Peer Groups
6.2.3.1. Benchmarking Analysis: North America (Peer Group I)
6.2.3.2. Benchmarking Analysis: North America (Peer Group II)
6.2.3.3. Benchmarking Analysis: Europe, Asia-Pacific and Rest of the World (Peer Group III)
6.2.3.4. Benchmarking Analysis: Europe, Asia-Pacific and Rest of the World (Peer Group IV)
6.2.3.5. Benchmarking Analysis: Europe, Asia-Pacific and Rest of the World (Peer Group V)
6.3. Benchmarking Analysis: Smart Biomaterials Developers
6.3.1. Assumptions and Key Parameters
6.3.2. Methodology
6.3.3. Benchmarking Analysis: Peer Groups
6.3.3.1. Benchmarking Analysis: North America (Peer Group I)
6.3.3.2. Benchmarking Analysis: North America (Peer Group II)
6.3.3.3. Benchmarking Analysis: Europe, Asia-Pacific and Rest of the World (Peer Group III)
6.3.3.4. Benchmarking Analysis: Europe, Asia-Pacific and Rest of the World (Peer Group IV)
6.3.3.5. Benchmarking Analysis: Europe, Asia-Pacific and Rest of the World (Peer Group V)

7. PRODUCT COMPETITIVENESS ANALYSIS
7.1. Chapter Overview
7.2. Assumptions and Key Parameters
7.3. Methodology
7.4. Product Competitiveness Analysis: Analysis by Location of Headquarters of 4D Bioprinter Developers
7.4.1. Product Competitiveness Analysis: 4D Bioprinters Developed by North America based Players
7.4.2. Product Competitiveness Analysis: 4D Bioprinters Developed by Europe based Players
7.4.3. Product Competitiveness Analysis: 4D Bioprinters Developed by Asia-Pacific and Rest of the World-based Players

8. COMPANY PROFILES
8.1. Chapter Overview
8.2. List of 4D Bioprinter Developers
8.2.1. Poietis
8.2.1.1. Company Overview
8.2.1.2. Product Portfolio
8.2.1.3. Recent Developments and Future Outlook
8.2.2. REGENHU
8.2.2.1. Company Overview
8.2.2.2. Product Portfolio
8.2.2.3. Recent Developments and Future Outlook
8.2.3. ROKIT Healthcare
8.2.3.1. Company Overview
8.2.3.2. Product Portfolio
8.2.3.3. Recent Developments and Future Outlook
8.2.4. SMART3D
8.2.4.1. Company Overview
8.2.4.2. Product Portfolio
8.2.4.3. Recent Developments and Future Outlook
8.2.5. Stratasys
8.2.5.1.1. Company Overview
8.2.5.1.2. Financial Information
8.2.5.1.3. Product Portfolio
8.2.5.1.4. Recent Developments and Future Outlook
8.2.6. VIVAX BIO
8.2.6.1. Company Overview
8.2.6.2. Product Portfolio
8.2.6.3. Recent Developments and Future Outlook
8.3. List of Smart Biomaterials Developers
8.3.1. DirectSync Surgical
8.3.1.1. Company Overview
8.3.1.2. Product Portfolio
8.3.1.3. Recent Developments and Future Outlook
8.3.2. Enovis
8.3.2.1. Company Overview
8.3.2.2. Financial Information
8.3.2.3. Product Portfolio
8.3.2.4. Recent Developments and Future Outlook
8.3.3. Ferentis
8.3.3.1. Company Overview
8.3.3.2. Product Portfolio
8.3.3.3. Recent Developments and Future Outlook
8.3.4. Sculpteo
8.3.4.1. Company Overview
8.3.4.2. Product Portfolio
8.3.4.3. Recent Developments and Future Outlook

9. PUBLICATION BENCHMARKING ANALYSIS
9.1. Chapter Overview
9.2. Scope and Methodology
9.2.1. Analysis by Year of Publication
9.2.2. Analysis by Type of Article
9.2.3. Word Cloud Analysis: Emerging Focus Areas
9.2.4. Popular Publishers: Analysis by Number of Publications
9.2.5. Popular Journals: Analysis by Number of Publications
9.2.6. Analysis by Journal Impact Factor
9.2.7. Popular Journals: Analysis by Journal Impact Factor
9.2.8. Popular Funding Bodies: Analysis by Number of Publications
9.2.9. Publications: Timeline Analysis
9.2.9.1. Timeline Analysis of Article Type
9.2.9.2. Timeline Analysis of Journal Impact Factor Range
9.2.10. Publication Benchmarking

10. PORTER’S FIVE FORCES ANALYSIS
10.1. Chapter Overview
10.2. Assumptions and Key Parameters
10.3. Methodology
10.3.1. Threats of New Entrants
10.3.2. Bargaining Power of Buyers
10.3.3. Bargaining Power of Suppliers
10.3.4. Threats of Substitute Products
10.3.5. Rivalry Among Existing Companies
10.4. Concluding Remarks

11. MARKET FORECAST AND OPPORTUNITY ANALYSIS
11.1. Chapter Overview
11.2. Forecast Methodology and Key Assumptions
11.3. Overall 4D Bioprinting Market, 2023-2035
11.3.1. 4D Bioprinting Market, 2028 and 2035: Distribution by Type of Technology
11.3.1.1. 4D Bioprinting Market for Extrusion-based Technology, 2023-2035
11.3.1.2. 4D Bioprinting Market for Laser-based Technology, 2023-2035
11.3.1.3. 4D Bioprinting Market for Inkjet-based Technology, 2023-2035
11.3.1.4. 4D Bioprinting Market for Other Technologies, 2023-2035
11.3.2. 4D Bioprinting Market, 2028 and 2035: Distribution by Application Area
11.3.2.1. 4D Bioprinting Market for Biomedical Applications, 2023-2035
11.3.2.2. 4D Bioprinting Market for Other Applications, 2023-2035
11.3.3. 4D Bioprinting Market, 2028 and 2035: Distribution by End-User
11.3.3.1. 4D Bioprinting Market for Pharmaceutical and Biotechnology Companies, 2023-2035
11.3.3.2. 4D Bioprinting Market for Academic Research and Development, 2023-2035
11.3.3.3. 4D Bioprinting Market for Other End-Users, 2023-2035
11.3.4. 4D Bioprinting Market, 2028 and 2035: Distribution by Key Geographical Regions
11.3.4.1. 4D Bioprinting Market in North America, 2023-2035
11.3.4.2. 4D Bioprinting Market in Europe, 2023-2035
11.3.4.3. 4D Bioprinting Market in Asia-Pacific, 2023-2035
11.3.4.4. 4D Bioprinting Market in Latin America, 2023-2035
11.3.4.5. 4D Bioprinting Market in Middle East and North Africa, 2023-2035
12. CONCLUDING REMARKS
13. EXECUTIVE INSIGHTS
13.1. Chapter Overview
13.2. Avay Biosciences
13.2.1. Company Overview
13.2.2. Interview Transcript: Suhridh Sundaram (Chief Operating Officer)
13.3. CURAM
13.3.1. Company Overview
13.3.2. Interview Transcript: Preethem Srinath (Doctoral Candidate)
13.3. Independent Consultant
13.3.1. Interview Transcript: Sam Onukuri
14. APPENDIX I: TABULATED DATA
15. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS